Table 1.
Overview of demographic data of the study cohort. * p < 0.05. n.s. stands for not significant.
| Controls (n = 20) 17 Female/3 Male |
Celiac Disease (n = 20) 19 Female/1 Male |
p-Value | |
|---|---|---|---|
| Age | 29.5 (median) |
30.0 (median) |
n.s. |
| SIBO-positive | 2/20 | 1/20 | n.s. |
| Body mass index (kg/m2) | 23.13 ± 4.60 | 23.22 ± 0.94 | n.s. |
| TEM (kPa) | 5.65 ± 0.59 | 4.39 ± 0.29 | n.s. |
| Body Fat Mass BIA (%) | 18.14 ± 9.62 | 19.74 ± 8.93 | n.s. |
| Total bile acids (µmol/L) | 4.43 ± 1.09 | 3.26 ± 0.04 | n.s. |
| Cholesterol (mg/dl) | 188.10 ± 39.50 | 194.80 ± 52.08 | n.s. |
| HDL (mg/dl) | 71.75 ± 18.58 | 62.95 ± 12.66 | n.s. |
| Triglycerides (mg/dl) | 79.50 ± 39.91 | 82.00 ± 37.01 | n.s. |
| HbA1c (%) | 5.33 ± 0.24 | 5.30 ± 0.34 | n.s. |
| Platelets (n/dl) | 240.50 ± 45.79 | 243.00 ± 56.59 | n.s. |
| INR | 0.99 ± 0.04 | 0.99 ± 0.05 | n.s. |
| ALT (U/L) | 19.30 ± 1.27 | 26.50 ± 4.57 | n.s. |
| AST (U/L) | 22.50 ± 2.53 | 22.35 ± 1.37 | n.s. |
| Alkaline phosphatase (U/L) | 60.25 ± 17.62 | 57.75 ± 13.19 | n.s. |
| Bilirubin (mg/dl) | 0.68 ± 0.32 | 0.63 ± 0.34 | n.s. |
| γGT (U/L) | 13.90 ± 7.35 | 18.30 ± 22.02 | n.s. |
| LDH (U/L) | 181.10 ± 51.28 | 168.10 ± 20.11 | n.s. |
| GLDH (U/L) | 2.81 ± 2.80 | 3.30 ± 2.35 | n.s. |
| M30 (U/L) | 88.91 ± 6.00 | 142.40 ± 21.40 | * |
| M65 (U/L) | 169.30 ± 14.18 | 200.40 ± 24.34 | n.s. |
| LBP1 (ng/mL) | 89.25 ± 16.05 | 89.66 ± 18.05 | n.s |
| Calprotectin, feces (µg/g) | 40.49 ± 4.99 | 52.60 ± 7.77 | n.s |